| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $4.6M | +139.2% |
| SG&A Expense | $8.5M | +18.3% |
| Operating Income | -$13.1M | -44.4% |
| Pre-tax Income | -$11.8M | -49.0% |
| Income Tax | $0 | — |
| Net Income | -$11.8M | -49.0% |
| EPS (Diluted) | -$0.81 | -24.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $40.3M | +40.0% |
| Total Assets | $41.0M | +39.3% |
| Current Liabilities | $425K | -12.7% |
| Stockholders' Equity | $40.5M | +40.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | -46.4% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $20.9M | +237.8% |